Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 Jul;36(7):1107–1114. doi: 10.1172/JCI103506

Renal Function in Wilson's Disease1

A G Bearn 1,2,3, T F Yü 1,2,3, A B Gutman 1,2,3
PMCID: PMC1072697  PMID: 13449163

Full text

PDF
1107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEARN A. G., KUNKEL H. G. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. J Clin Invest. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BEYER K. H. Functional characteristics of transport mechanisms. J Pharmacol Exp Ther. 1950 Aug;99(42):227–280. [PubMed] [Google Scholar]
  3. BEYER K. H., RUSSO H. F., TILLSON E. K., MILLER A. K., VERWEY W. F., GASS S. R. 'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination. Am J Physiol. 1951 Sep;166(3):625–640. doi: 10.1152/ajplegacy.1951.166.3.625. [DOI] [PubMed] [Google Scholar]
  4. BISHOP C., ZIMDAHL W. T., TALBOTT J. H. Uric acid in two patients with Wilson's disease (hepatolenticular degeneration). Proc Soc Exp Biol Med. 1954 Jul;86(3):440–441. doi: 10.3181/00379727-86-21124. [DOI] [PubMed] [Google Scholar]
  5. BUSH J. A., MAHONEY J. P., MARKOWITZ H., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J Clin Invest. 1955 Dec;34(12):1766–1778. doi: 10.1172/JCI103232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., WINTROBE M. M., BEAN W. B. Studies on copper metabolism. XIII. Hepatolenticular degeneration. J Clin Invest. 1954 Nov;33(11):1487–1501. doi: 10.1172/JCI103027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cooper A. M., Eckhardt R. D., Faloon W. W., Davidson C. S. INVESTIGATION OF THE AMINOACIDURIA IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION): DEMONSTRATION OF A DEFECT IN RENAL FUNCTION. J Clin Invest. 1950 Mar;29(3):265–278. doi: 10.1172/JCI102254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. ENGLE R. L., Jr, WALLIS L. A. The adult Fanconi syndrome. II. Review of eighteen cases. Am J Med. 1957 Jan;22(1):13–23. [PubMed] [Google Scholar]
  9. HODGES R. E., KIRKENDALL W. M., GUBLER C. J. Some aspects of kidney function in hepatolenticular degeneration (Wilson's disease). J Lab Clin Med. 1956 Mar;47(3):337–342. [PubMed] [Google Scholar]
  10. MAHONEY J. P., SANDBERG A. A., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Uric acid metabolism in hepatolenticular degeneration. Proc Soc Exp Biol Med. 1955 Mar;88(3):427–430. doi: 10.3181/00379727-88-21608. [DOI] [PubMed] [Google Scholar]
  11. MATTHEWS W. B., MILNE M. D., BELL M. The metabolic disorder in hepato-lenticular degeneration. Q J Med. 1952 Oct;21(84):425–446. [PubMed] [Google Scholar]
  12. MATTHEWS W. B. The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson's disease). J Neurol Neurosurg Psychiatry. 1954 Nov;17(4):242–246. doi: 10.1136/jnnp.17.4.242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pitts R. F., Ayer J. L., Schiess W. A., Miner P. THE RENAL REGULATION OF ACID-BASE BALANCE IN MAN. III. THE REABSORPTION AND EXCRETION OF BICARBONATE. J Clin Invest. 1949 Jan;28(1):35–44. doi: 10.1172/JCI102050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  15. SIROTA J. H., HAMERMAN D. Renal function studies in a adult subject with the Fanconi syndrome. Am J Med. 1954 Jan;16(1):138–152. doi: 10.1016/0002-9343(54)90329-0. [DOI] [PubMed] [Google Scholar]
  16. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. STEIN W. H., BEARN A. G., MOORE S. The amino acid content of the blood and urine in Wilson's disease. J Clin Invest. 1954 Mar;33(3):410–419. doi: 10.1172/JCI102913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WARNOCK C. G. Hepatolenticular degeneration; Wilson's disease; a report of five cases, with commentary. Ulster Med J. 1952 Nov 1;21(2):155–171. [PMC free article] [PubMed] [Google Scholar]
  19. WINTROBE M. M., CARTWRIGHT G. E., HODGES R. E., GUBLER C. J., MAHONEY J. P., DAUM K., BEAN W. B. Copper metabolism in Wilson's disease. Trans Assoc Am Physicians. 1954;67:232–241. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES